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Functional statusAccording to the ﬁndings of some recent studies, the centenarians' offspring appear to represent a promising
model for research on longevity and healthy aging. This study compares the health status and the functional
status of three groups of subjects: 1. individuals with two long-lived parents (one of whom centenarian), 2.
individuals with only one long-lived (centenarian) parent, and 3. individuals with no long-lived parents.
The goal is to verify whether the centenarians' offspring display any advantage over the offspring of both
non-long-lived parents and to evaluate whether the longevity of the non-centenarian parent provides a
further advantage. A total of 374 subjects (mean age approximately 70 years) was examined. A threshold
for longevity was established for non-centenarian parents through demographic data available for Italy
(males surviving to at least 81 years of age and females to 87 years). The participants were assessed for
their health and functional status by means of a standardized questionnaire and tests of physical perfor-
mance. Data were analyzed using multivariate regression models adjusted for socio-demographic character-
istics and risk factors for age-related pathologies.
The results of the study show that centenarians' offspring have a better functional status, a reduced risk for
several age-related pathologies and reduced drug consumption than the offspring of non-long-lived parents.
In addition, the health status of centenarians' offspring does not appear to be inﬂuenced by the longevity of
the second parent. It therefore seems possible to conclude that at ages around 70 years the genetic contribu-
tion to health status deriving from having one centenarian parent is not substantially improved if the other
parent is also long-lived.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Over the past twenty years, centenarians have represented a valu-
able resource for the study of phenotypic characteristics of extreme
aging and the genetic and environmental factors of longevity. The







rights reserved.and tissues in order to cope with the lifelong exposure to biological,
physical and chemical stressors, so that longevity can be attained by
efﬁcient mechanisms of adaptation and remodeling capacity. Indeed,
the centenarians display a peculiar, complex and heterogeneous phe-
notype, which might be the result of a better capacity of their body to
adapt and remodel in response to biological and non-biological stim-
uli (Franceschi et al., 2000, 2007b).
Moreover, centenarians seem to reach their extreme age thanks to
a slower aging process and have a lower prevalence of cancer (Salvioli
et al., 2009), cardiovascular diseases (CVD) (Olivieri et al., 2008),
insulin-resistance and diabetes (Paolisso et al., 1996) and delay of
about 1–2 decades the onset of others pathologies such as dementia
and osteoporothic fractures (Evert et al., 2003; Passeri et al., 2003).
Furthermore, the great majority of them has optimal anthropomet-




















Fig. 1. Distribution of Italian male deaths in ﬁve quinquennial birth cohorts according
to the estimates of the Human Mortality Database (dx=number of deaths occurring
between the age x and the age x+1 in a cohort of 100,000 births). The vertical dashed
line indicates the longevity threshold.
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parameters for their age (Spazzafumo et al., 2011).
However, research on centenarians has to face several methodo-
logical difﬁculties. The ﬁrst is the rarity of centenarians (e.g. in Italy
about 27 for every 100,000 residents at 1st January 2011 according
to the National Institute of Statistics ISTAT), which makes recruitment
rather difﬁcult. Moreover, it is very hard to perform population-based
cross-sectional studies on centenarians (Gueresi et al., 2003) due
to the very high mortality rate at extremely advanced ages. Finally,
there is no appropriate control group for centenarians.
No less important are the ethical and practical questions that have
to be dealt with when approaching subjects who are very frail and
sometimes easily tired.
Recently, the attention of some researchers has focused on the off-
spring of centenarians as a model for longevity and healthy aging.
Longevity is known to have a strong familial (and genetic) compo-
nent (De Benedictis and Franceschi, 2006; Franceschi et al., 2007a)
and recent studies suggest that the offspring of centenarians have a
signiﬁcant survival advantage, a higher probability to become long-
lived and a lower risk of age-related diseases, such as cardio- and
cerebro-vascular diseases, compared to control subjects (Adams et
al., 2008; Atzmon et al., 2004; Perls et al., 2002; Terry et al., 2003,
2004a,b). At the same time, the study of the offspring of centenarians
reduces or resolves the disadvantages related to research on cente-
narians themselves. Being younger, their offspring are less rare and
easier to recruit, less frail and less likely to die within short time.
Moreover, they can be compared with age-matched control groups.
The research project “Does the longevity of parents inﬂuence the
health status of their offspring?” supported by the Ministry of Educa-
tion, University and Research (MIUR), aims to evaluate the role of
longevity in one or both parents on the quality of their offspring's
aging and to identify biological parameters and genetic polymor-
phisms related to healthy aging. This paper will present the study de-
sign and will compare the offspring of centenarians and the offspring
of subjects who were not long-lived as regards several phenotypic
characteristics. The goal is to verify whether the children of centenar-
ians display any advantage when compared to the offspring of
non-long-lived subjects, evaluating at the same time whether having
two long-lived parents (one of whom centenarian) represents a fur-
ther advantage over having only one long-lived (centenarian) parent.
It is worth noting that an accurate demographic analysis of the age of
the non-centenarian parent was performed, giving a further value to
this study since it was never taken into consideration in previous re-
search on centenarians' offspring.
The studied variables concern both objective and perceived state
of health, with special attention on the physical–functional state as
well as on the pathologies and risk factors related to the main causes
of death among the elderly.
2. Materials and methods
2.1. Deﬁning longevity criteria for group identiﬁcation
The aims of the study entailed the need to compare three groups of
subjects: 1. offspring of two long-lived parents, one of whom cente-
narian (LL); 2. offspring of one centenarian parent and one non-
long-lived parent (NL); and 3. offspring of both non-long-lived
parents (NN).
In order to identify the above mentioned groups, rigorous demo-
graphic criteria were applied to establish the threshold age over
which subjects were classiﬁed as long-lived. These criteria take into
account the distribution of deaths, according to the estimates of the
Human Mortality Database for the ﬁve-year birth cohorts to which
the parents of the subjects recruited belong. Since it was decided to
recruit, in 2007 and 2008, offspring of at least one living centenarian
parent, born therefore presumably between 1900 and 1908, the birthcohorts of the centenarians' spouses were estimated to fall between
1890–94 and 1910–14 cohorts. The parents of NN subjects belong to
the same cohorts.
According to estimates from the Human Mortality Database, dis-
tribution of Italian male deaths in the cohorts of interest (excluding
deaths occurred before the age of 15 years) has the form of a nega-
tively asymmetrical curve (Fig. 1), although distribution during the
1890–94 and 1895–99 cohorts is sharply altered by the effects on
mortality of the First World War. The effects of aging on mortality
start to become apparent from about the age of ﬁfty. In the central co-
hort 1900–1904 the 85th-percentile of the distribution of all deaths
falls between the 81st and the 82nd birthday, therefore about 15%
of all male deaths in this birth cohort occurred at or over the age of
81 years. It was decided to consider as non-long-lived males those
deceased before reaching the age of 81 years. This longevity thresh-
old can be considered essentially valid also for the previous and sub-
sequent ﬁve-year birth cohorts despite the different life expectancy of
the cohorts. In fact, although the threshold value causes the number
of deaths per cohort to be apportioned differently, so that the
long-lived may be little more or little less than 15%, it lies in the de-
scending phase of the curve of deaths.
Using the same procedure, females deceased before reaching the
age of 87 years were considered to be non-long-lived (Fig. 2).2.2. Recruitment and data collection
A list of eligible subjects for the study was obtained thanks to the
help from Registry Ofﬁces in ﬁve Italian cities (Bologna, Milan, Florence,
Parma and Palermo) and surrounding areas. Offspring of parents who
died from accidental causes were excluded. A total of 374 subjects
were recruited and attributed to the LL, LN and NN groups on the
basis of the previously illustrated demographic criteria.Where possible,
for each centenarian the oldest child was contacted. Centenarian par-
ents were still alive at the time of the interview. Themean and standard
deviation of the age at death of the second parent were 89.1±4.7 for
the LL group and 66.2±12.4 for the LN group. In the NN group, the
oldest parent died at a mean age of 64.6±7.0, while the youngest died
at a mean age of 53.5±10.9.
The study protocol was approved by the Ethical Committee of
Sant'Orsola-Malpighi University Hospital (Bologna, Italy).
The recruited subjects were examined in their own homes by a
team composed by a physician and a biologist speciﬁcally trained to
gather the data. Besides undergoing an objective exam and giving a
blood sample, the participants answered a questionnaire which
covered socio-demographic characteristics, lifestyle, pathological




















Fig. 2. Distribution of Italian female deaths in ﬁve quinquennial birth cohorts according
to the estimates of the Human Mortality Database (dx=number of deaths occurring
between the age x and the age x+1 in a cohort of 100,000 births). The vertical dashed
line indicates the longevity threshold.
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and cognitive performances.
Regarding the evaluation of general state of health, typical
age-related diseases and the pathological conditions representing the
main causes of death among the elderly were considered. Pathologies
and chronic conditions are documented bymedical reports or by speciﬁc
ongoing therapies.
It should be pointed out that the data reported here have not been
gathered in order to estimate the prevalence of pathological condi-
tions. This is particularly true in the case of cancer, since subjects
with severe health problems due to overt cancer have been excluded
from the study.
Chronic therapies (i.e. daily drug consumption under medical pre-
scription, such as cardiovascular, antihypertensive, lipid-lowering and
anti-diabetic drugs) and the number of drugs taken dailywere included
in the analysis as general health indicators.
Finally, perceived health state of subjects was considered. The ap-
proach was devised to include both qualitative (state of health self-
evaluated as “very good”, “good”, “normal”, “poor” or “very poor”)
and quantitative assessments (self-rated state of health with a score
ranging from 0 to 100). Perceived health has been reported dichoto-
mously because very few subjects claimed that their health was
“poor” or “very poor”.
The functional status of the participants was described by an item
concerning their ability to walk 500 m without help or device. More-
over, hand grip strengthwasmeasuredwith a Smedley's dynamometer
(Scandidact, Kvistgaard, Denmark) and the best of two performancesTable 1
Socio-demographic characteristics, lifestyle and bodymass index (BMI) in subjects with two lon
(NN). p-values refer to univariate statistics (ANOVA, Kruskal–Wallis, Chi-square test or Fisher'
Gendera Males, %(n)
Females, %(n)
Marital statusb Married, %(n)
Unmarried, widowed, divorced, %(n)
Smoking habits Smokers, %(n)
Non-smokers, %(n)
Wine consumption Teetotalers, %(n)
1–2 glasses/day, %(n)
3 or more glasses/day, %(n)
Regular physical exercise Yes, %(n)
No, %(n)
Age Mean±SD (n)
Education yearsa Mean±SD (n)
BMI (kg/m2) males Mean±SD (n)
BMI (kg/m2) femalesa Mean±SD (n)
a pb0.05.
b pb0.01.with the dominant hand was considered for the analysis. The chair-
stand test was also performed, i.e. the time taken to sit down–stand
up from a chair ﬁve consecutive times.
Socio-demographic characteristics like gender, age, marital status,
education (years), as well as several recognized risk factors for
age-related pathologies, such as smoking (present or past smoking
for at least 10 years or at least 10 cigarettes a day), wine consumption
(number of glasses drunk daily during lifetime), BMI (normal and un-
derweight vs. overweight and obese) and physical activity (subjects
who claimed to practice regular physical exercise vs. subjects who
did not) were considered as possible confounders.
2.3. Data and statistical analysis
Socio-demographic, functional and clinical characteristics in the
three groups of subjects with two, one or no long-lived parents have
been ﬁrstly examined by means of univariate statistics (ANOVA,
Kruskal–Wallis, Chi-square test or Fisher's exact test, as appropriate).
For a more thorough investigation of the relations among functional
status or health status and the three groups, severalmultiple regression
models have been developed. Regression models were adjusted for the
effects of gender, age, marital status, education, BMI, physical activity,
smoking and wine consumption.
The continuous dependent variables were studied with multivari-
ate linear regression models and regression coefﬁcients with 95%
conﬁdence interval (CI) were reported. The dichotomous dependent
variables were analyzed with logistic regression models and the
odds ratio (OR) with 95% conﬁdence interval was used as a measure
of association. When the dependent variable represented a count
(i.e. the number of drugs assumed), a Poisson regression model was
estimated and the incidence rate ratio with 95% CI was reported.
3. Results
Table 1 shows the general characteristics of subjects with two
long-lived parents, one of which centenarian (LL), those with only
one long-lived (centenarian) parent (LN), and subjects without
long-lived parents (NN). The number of cases is greater in LN group,
enabling the continuation of the study to include a possible subdivi-
sion of this group according to the gender of the long-lived/non-
long-lived parents. The gender composition of the groups is balanced
somewhat in favor of the females in LN group, where there is also a
signiﬁcantly lower proportion of married subjects. Among the
socio-demographic variables there are also signiﬁcant differences in
education level, higher in LL group.g-lived parents (LL), with only one long-lived parent (LN) andwithout long-lived parents
s exact test, as appropriate).
LL (n=83) LN (n=183) NN (n=107)
49.4 (41) 36.6 (67) 51.4 (55)
50.6 (42) 63.4 (116) 48.6 (52)
69.9 (58) 54.6 (100) 76.6 (82)
30.1 (25) 45.4 (83) 23.4 (25)
43.4 (36) 45.4 (83) 43.0 (46)
56.6 (47) 54.6 (100) 57.0 (61)
34.1 (28) 47.1 (81) 39.4 (41)
56.1 (46) 48.3 (83) 53.9 (56)
9.8 (8) 4.6 (8) 6.7 (7)
62.2 (51) 63.9 (117) 69.8 (74)
37.8 (31) 36.1 (66) 30.2 (32)
69.0±6.2 (83) 70.8±6.6 (183) 71.1±6.0 (107)
12.1±5.2 (83) 10.8±4.9 (183) 10.1±4.3 (107)
26.8±2.7 (41) 27.0±3.9 (65) 27.8±3.9 (55)
25.7±4.4 (41) 26.5±5.2 (113) 28.5±4.5 (51)
Table 2
Functional status and perceived health in subjects with two long-lived parents (LL), with only one long-lived parent (LN) and without long-lived parents (NN). p-values refer to
univariate statistics (ANOVA, Kruskal–Wallis, Chi-square test or Fisher's exact test, as appropriate).
LL (n=83) LN (n=183) NN (n=107)
Ability to walk 500 m without help Yes, %(n) 96.3 (79) 95.1 (174) 89.6 (95)
No, %(n) 3.7 (3) 4.9 (9) 10.4 (11)
Ability to perform the chair-stand testa Yes, %(n) 97.1 (68) 95.3 (161) 84.6 (88)
No, %(n) 2.9 (2) 4.7 (8) 15.4 (16)
Chair-stand (s) males Mean±SD (n) 11.1±3.8 (31) 11.0±2.8 (58) 11.7±4.4 (48)
Chair-stand (s) females Mean±SD (n) 12.1±4.9 (37) 12.6±4.9 (102) 13.4±3.3 (40)
Hand grip strength (kg) males Mean±SD (n) 39.4±7.5 (41) 37.7±7.0 (67) 37.4±7.4 (54)
Hand grip strength (kg) femalesa Mean±SD (n) 23.8±6.7 (42) 23.8±5.1 (110) 21.2±5.0 (51)
Self-rated health score (0–100) Mean±SD (n) 77.0±13.1 (82) 76.3±16.7 (183) 72.7±16.5 (105)
Perceived health Good or very good, %(n) 62.2 (51) 62.4 (113) 50.0 (52)
Normal, poor or very poor, %(n) 37.8 (31) 37.6 (68) 50.0 (52)
a pb0.05.
Table 4
Synthesis of the multivariate regression models in which the dependent variables
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are higher in NN group, but differences are signiﬁcant only in females.
A better functional status in the LL and LN groups in comparison
with NN group is revealed by signiﬁcant differences in the ability to
perform the chair-stand test and, among females, in the hand grip
strength (Table 2). Among those who were able to conclude the
chair-stand test, NN group on average shows the worst performance,
however the differences are not statistically signiﬁcant. Moreover, in
the group in which neither parent was long-lived, both the percent-
age of subjects who consider their health status as good or very
good and the self-rated health score are lower, even though not sig-
niﬁcantly (Table 2).
A notable variability in the presence of pathologies can be observed
in the three groupswith different parental longevity (Table 3). In partic-
ular, systematically higher percentages of subjects suffering from pa-
thologies or who exhibit risk factors for age-associated diseases are
recorded in the group with no long-lived parents. The differences be-
tween the groups are signiﬁcant in their need for chronic therapy and
number of drugs taken daily, as well as for frequency of cancer, hyper-
tension, myocardial infarction and stroke/thrombosis/cerebral hemor-
rhage. Finally, it can also be noted that for two other pathological
conditions, chronic obstructive pulmonary disease (COPD) and chronic
renal failure, the differences between the groups are close to statistical
signiﬁcance (respectively 0.062 and 0.061).Table 3
Health status in subjects with two long-lived parents (LL), with only one long-lived
parent (LN) and without long-lived parents (NN). p-values refer to univariate statistics









Yes, %(n) 7.3 (6) 5.0 (9) 17.3 (18)
No, %(n) 92.7 (76) 95.0 (172) 82.7 (86)
Hypertensionb Yes, %(n) 37.4 (31) 41.5 (76) 63.6 (68)
No, %(n) 62.6 (52) 58.5 (107) 36.4 (39)
Hypercholesterolemia Yes, %(n) 36.1 (30) 33.3 (61) 42.5 (45)
No, %(n) 63.9 (53) 66.7 (122) 57.5 (61)
Diabetes Yes, %(n) 8.4 (7) 10.4 (19) 11.3 (12)
No, %(n) 91.6 (76) 89.6 (164) 88.7 (94)
Cancera Yes, %(n) 7.2 (6) 11.1 (20) 19.1 (20)
No, %(n) 92.8 (77) 88.9 (161) 80.9 (85)
COPD Yes, %(n) 1.2 (1) 4.4 (8) 8.5 (9)
No, %(n) 98.8 (82) 95.6 (175) 91.5 (97)
Chronic renal failure Yes, %(n) 2.4 (2) 0.6 (1) 4.7 (5)
No, %(n) 97.6 (81) 99,4 (182) 95.3 (101)
Chronic therapyb Yes, %(n) 72.3 (60) 80.9 (148) 93.4 (99)












b pb0.01.Table 4 shows a synthesis of the results of the multivariate models
in which the dependent variables emerged as signiﬁcantly associated
with parental longevity. The reference category in all the models is
the NN group, i.e. subjects with non-long-lived parents.
Concerning the ability to walk 500 m unassisted, LL and LN groups
have a higher odds ratio in comparison to NN subjects even though
this difference reaches statistical signiﬁcance only for LN subjects.
The ability to perform the chair-stand test and hand grip strength
are signiﬁcantly higher in LN group than in NN group. LL group
shows a similar trend to group LN, with p-values close to statistical
signiﬁcance (p=0.058 in both cases).
Regarding pathologies and related aspects, a reduced risk is ob-
served in LN and LL subjects compared to NN subjects.
Considering both qualitative and quantitative assessments of per-
ceived health, the most favorable group is that with one long-lived
parent. The same applies as concerns the onset of infarction or stroke
(these two pathologies have been considered together in order to in-
crease the number of affected cases in the analysis). LL group appears
to be signiﬁcantly favored for cancer and chronic obstructive pulmo-
nary disease (COPD), however the odds ratio for LN group is not far
from statistical signiﬁcance (p=0.065 and p=0.083, respectively).emerged as signiﬁcantly associated with parental longevity. All the models adjusted
for socio-demographic characteristics, BMI, physical activity, smoking and wine
consumption.
Variable Groupa Effect measure estimate
(95% CI)
p-Value
Ability to walk 500 m
without help
LN OR: 5.113 (1.586 16.485) 0.001
LL OR: 4.911 (0.909 26.519) 0.064
Ability to perform the
chair-stand test
LN OR: 5.031 (1.709 14.812) 0.006
LL OR: 4.629 (0.882 24.291) 0.070
Hand grip strength LN β: 1.661 (0.213 3.109) 0.025
LL β: 1.495 (−0.195 3.185) 0.083
Self-rated health score LN β: 4.072 (0.087 8.058) 0.045
LL β: 3.310 (−1.349 7.968) 0.163
Perceived health “good”
or “very good”
LN OR: 2.080 (1.208 3.575) 0.008
LL OR: 1.368 (0.728 2.569) 0.330
Stroke or myocardial infarction LN OR: 0.238 (0.089 0.639) 0.004
LL OR: 0.479 (0.169 1.356) 0.166
Hypertension LN OR: 0.457 (0.260 0.803) 0.006
LL OR: 0.481 (0.250 0.927) 0.029
Cancer LN OR: 0.500 (0.239 1.044) 0.065
LL OR: 0.371 (0.138 0.997) 0.049
COPD LN OR: 0.366 (0.118 1.138) 0.083
LL OR: 0.115 (0.013 0.988) 0.049
Chronic therapy LN OR: 0.304 (0.123 0.752) 0.010
LL OR: 0.232 (0.090 0.600) 0.003
Number of drugs taken daily LN IRR: 0.635 (0.551 0.730) b0.001
LL IRR: 0.664 (0.555 0.795) b0.001
Signiﬁcant p-values are reported in italics.
a NN group is the reference category.
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ents in comparison to non-long-lived parents appears very similar for
hypertension, use of chronic therapy and number of drugs taken daily.
Using the estimates obtained from the multivariate models, the
comparison between the LL and LN groups did not show statistically
signiﬁcant differences for each dependent variable.4. Discussion
The aim of this study was to evaluate the advantage, in terms of
health and functional status, that may derive from having one cente-
narian parent and one long-lived or, alternatively, one centenarian
parent and one non-long-lived, in comparison with the condition of
those with neither parents long-lived. To this end it was decided to
apply a restrictive demographic criterion to deﬁne when considering
the second parent long-lived or not. This criterion was based on death
distribution estimates for the birth cohorts of reference, so as to guar-
antee that death occurred at a later age than the modal ages of death.
The results obtained in this work seem to indicate that the state of
health of subjects without long-lived parents is on the whole worse
than the health of individuals with one or two long-lived parents.
This trend emerges clearly for pathologies concerning the three
main groups of death causes in the elderly, i.e. cardiovascular diseases
with related risk factors, cancer and respiratory diseases. Moreover,
the fact that subjects with at least one long-lived parent have a signif-
icantly reduced risk of taking drugs for chronic therapy, and take a
signiﬁcantly reduced number of drugs when compared to the NN sub-
jects, is worth noting because the use of drugs can effectively synthe-
size the overall state of health.
Our results concerning the risk of age-related diseases and the use
of drugs in centenarians' offspring compared to age-matched controls
are consistent with data obtained in previous studies and reinforce
the notion that longevity runs in families and that centenarians' off-
spring are more likely to age in better health and with a lowermortal-
ity than their peers (Adams et al., 2008). Recent studies suggest that
these observations can be also applied to nonagenarian families. In-
deed, data from the Leiden Longevity Study on offspring of nonage-
narian siblings indicate a preserved insulin sensitivity, a lower
prevalence of myocardial infarction, hypertension, diabetes mellitus
and use of cardiovascular medication with respect to their partners
(Westendorp et al., 2009; Wijsman et al., 2011).
For the ﬁrst time this study extends the comparison between cen-
tenarians' offspring and offspring of non-long-lived parents to func-
tional status assessment, an extremely important factor in the
general state of health of the elderly. Signiﬁcant or almost signiﬁcant
differences in the ability to perform the chair-stand test and, for
women, hand grip strength have been observed. A previous work, an-
alyzing offspring of nonagenarian subjects, suggested that handgrip
was not a marker of familial longevity (Ling et al., 2012). This appar-
ent discrepancy may be due to the different ages of offspring partici-
pants in the two studies. In particular, the subjects recruited in our
study, being offspring of centenarians, are ten years older on average,
attaining an age critical for the onset of age-related decline. However,
it can be hypothesized that at older ages the differences in functional
and health status might emerge more clearly.
Moreover, the fact that differences in the hand grip strength are
signiﬁcant among females and not among males is in line with the
general observation that, in the elderly, men enjoy better functional
status than women of the same age (Crimmins et al., 2011) and
does not rule out the possibility that the differences between the
groups may appear in older males.
The parents' longevity seems also to impact on body mass index,
even though only in females signiﬁcantly. It is observed in fact that
LL group has the lowest values, while NN group has the highest.
This aspect is worth noting because the BMI seems to act as aconfounding variable in the regression models, either concerning
functional status or pathologies and the use of pharmaceutical drugs.
Although for some of the variables analyzed a signiﬁcant difference
was sometimes noted only for one of the two LL or LN groups in com-
parison with the NN group, overall the advantage in state of health of
this sample of people around 70 years of age appears similar between
thosewith one or both long-lived parents. Indeed, on thewhole, the co-
efﬁcient values of regression or the odds ratios are similar in the two
groups, and often when p-values reach statistical signiﬁcance in one
of the two groups they are not far removed either. It therefore seems
possible to conclude that at ages around 70 years the genetic contribu-
tion to health status deriving from having one centenarian parent is not
substantially improved if the other parent is also long-lived. Thisﬁnding
is reinforced by the fact that, as discussed earlier, it was decided to
choose a rather high threshold for longevity (81 years or older for
males and 87 years or older for females).
Indeed, diverse studies show that the genetic inﬂuence on aging is
the highest in extremely long-living individuals and that the herita-
bility of longevity increases with the increase of the threshold used
to deﬁne longevity (Cevenini et al., 2010; Gögele et al., 2011). Some
genetic effect would probably be observed in the strongly unlikely
event that also the second parent was extremely long-lived.
In conclusion, the results of this study conﬁrm largely that the off-
spring of centenarians represent an appropriate model for research on
healthy aging, suggesting that the longevity of the non-centenarian par-
ent seems to be irrelevant for the functional and general health status of
the offspring. However, our results refer to a sample of subjects with a
mean age of about 70 years and do not exclude that at older ages the
longevity of the second parent can became a relevant factor. Further
studies are needed to answer this interesting question, in particular it
is urgent to plan a longitudinal study, checking periodically the health
status of the participants.Acknowledgements
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